Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...
Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today announced positive results from a prospective, ...
Publishedmulticenter study found higher complete wound closure rates and faster healing with Symphony plus standard of ...
Immix Biopharma (NASDAQ:IMMX) reported updated clinical data for NXC-201, its investigational CAR T-cell therapy for relapsed or refractory light-chain (AL) amyloidosis, and outlined plans for a ...
Preeclampsia remains one of the most feared complications of pregnancy, a condition in which dangerously high blood pressure ...
Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...
A landmark real-world study from China has delivered striking news for patients with one of the most common forms of blood ...
More adults with chronic spontaneous urticaria receiving CUE-221, a humanized anti-IgE IgG1 monoclonal antibody, achieved complete resolution of hives vs. placebo on drug and 12 weeks off drug, ...
Substantially all planned REO 033 clinical sites are now activated, with multiple patients currently on study Company expects to have sufficient Part A data to provide an interim clinical update by ...
Substantially all planned REO 033 clinical sites are now activated, with multiple patients currently on studyCompany expects to have sufficient ...
Design of experiments is extremely important.And yet, despite its importance, it is surprisingly neglected.When working in ...
T cell receptor (TCR) gene transfer is a promising approach for cancer immunotherapy, but its efficacy is limited by mispairing of TCR chains, which reduces surface expression and may generate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results